Eagle Pharmaceuticals
EGRX
#10303
Rank
HK$85.86 M
Marketcap
HK$6.63
Share price
0.00%
Change (1 day)
32.95%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$85.86 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of HK$85.86 Million. This makes Eagle Pharmaceuticals the world's 10303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$85.86 M89.26%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$85.86 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.107 T 4,782,838.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$759.74 B 884,687.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$2.159 T 2,514,390.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
HK$284.06 B 330,715.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$1.387 T 1,615,220.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.257 T 8,451,316.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$877.00 B 1,021,242.55%๐Ÿ‡บ๐Ÿ‡ธ USA